The C5 Life Sciences IP Summit will explore the latest legal information and challenges assessment for pharmaceutical and biotech companies, as well as continuing to address patent legal environment for medical device companies.
Dominic Adair will be speaking at a workshop titled: ‘International Biosimilars Think Tank: Exploring the Biosimilar Landscape in the U.S. and Europe’, at 1pm on Monday 14 October. This will be split into sections:
- Part 1 – Exploring the U.S. Biologics Price Competition Innovation Act (BPCIA)
- Part 2 – European Biosimilar Update and Strategic Considerations
- Part 3 – Mock Scenario
For more information, see the C5 website.